DCOY
Decoy Therapeutics Inc.

111
Mkt Cap
$4.05M
Volume
17.00
52W High
$415.80
52W Low
$6.18
PE Ratio
-0.02
DCOY Fundamentals
Price
$8.01
Prev Close
$7.62
Open
$7.58
50D MA
$8.89
Beta
0.12
Avg. Volume
15,047.30
EPS (Annual)
-$1,043.06
P/B
0.14
Rev/Employee
$0.00
$0.4422
Loading...
Loading...
News
all
press releases
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform Decoy Therapeutics Enters Strategic...
PR Newswire·6d ago
News Placeholder
More News
News Placeholder
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split Decoy Therapeutics Announces 1-for-12 Reverse Stock Split PR Newswire CAMBRIDGE, Mass., March 5, 2026 CAMBRIDGE, Mass., March 5, 2026...
PR Newswire·12d ago
News Placeholder
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
Decoy Therapeutics Joins Webull Corporate Connect Service Platform Decoy Therapeutics Joins Webull Corporate Connect Service Platform PR Newswire CAMBRIDGE, Mass. and HOUSTON, Feb. 11, 2026 - Connect...
PR Newswire·1mo ago
News Placeholder
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial Decoy Therapeutics to Participate in the Corporate Connect Webinar Series...
PR Newswire·1mo ago
News Placeholder
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform Decoy Therapeutics Reaches Global...
PR Newswire·2mo ago
<
...
1
>

Latest DCOY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.